HealthpointCapital backs surgical workflow startup Ospitek in growth round
What's the deal? HealthpointCapitalDealroom has a profile for this one. Try Dealroom → has made a growth equity investment in OspitekDealroom has a profile for this one. Try Dealroom →, a San Diego-based maker of surgical operations and patient-flow software. The firm led the round, announced October 13, 2026. Transaction details were not disclosed.
What does Ospitek do? Its platform delivers real-time visibility across the surgical episode of care, using artificial intelligence, automation, and analytics to synchronise teams and automate communication. The technology helps hospitals and surgery centres benchmark performance, spot inefficiencies, and improve operating room throughput.
What's the money for? HealthpointCapital will fund Ospitek's technology platform, commercial team, customer success capabilities, and product development. The company targets ambulatory surgery centres, specialty hospitals, and broader healthcare settings.
Why now? "Hospitals and surgery centers are laser-focused on driving efficiency while improving patient, surgeon and staff satisfaction," said Mike Mogul, managing partner at HealthpointCapital. Chief executive officer Slim Souissi said the partnership would "accelerate innovation, expand our capabilities, and bring our technology to more surgical facilities across the country."
What's the backer's play? HealthpointCapital invests exclusively in musculoskeletal healthcare, with past exits including CrossRoads Extremity SystemsDealroom has a profile for this one. Try Dealroom →, OrthoSpace, Blue Belt TechnologiesDealroom has a profile for this one. Try Dealroom →, and BioHorizons. It also backs SteriCUBEDealroom has a profile for this one. Try Dealroom →, a surgical equipment flow system, pointing to a strategy of building tools that help surgical centres scale.
The signal: The deal reflects growing demand for workflow automation and operational intelligence across ambulatory surgery centres, where operators face pressure to lift throughput without adding cost. For a musculoskeletal-focused investor, software that squeezes more capacity from existing facilities is an increasingly central bet.
Read more: prnewswire.com
Image credit: U.S. Naval Forces Central Command/U.S. Fifth Fleet
